11495417

Source:http://linkedlifedata.com/resource/pubmed/id/11495417

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:11495417	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:11495417	lifeskim:mentions	umls-concept:C0026769	lld:lifeskim
pubmed-article:11495417	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:11495417	lifeskim:mentions	umls-concept:C0475463	lld:lifeskim
pubmed-article:11495417	lifeskim:mentions	umls-concept:C0244713	lld:lifeskim
pubmed-article:11495417	pubmed:issue	2	lld:pubmed
pubmed-article:11495417	pubmed:dateCreated	2001-8-9	lld:pubmed
pubmed-article:11495417	pubmed:language	eng	lld:pubmed
pubmed-article:11495417	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:11495417	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11495417	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:11495417	pubmed:issn	0393-5264	lld:pubmed
pubmed-article:11495417	pubmed:author	pubmed-author:HorowskiRR	lld:pubmed
pubmed-article:11495417	pubmed:author	pubmed-author:KappJ FJF	lld:pubmed
pubmed-article:11495417	pubmed:author	pubmed-author:StürzebecherC...	lld:pubmed
pubmed-article:11495417	pubmed:issnType	Print	lld:pubmed
pubmed-article:11495417	pubmed:volume	16	lld:pubmed
pubmed-article:11495417	pubmed:owner	NLM	lld:pubmed
pubmed-article:11495417	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:11495417	pubmed:pagination	117-28	lld:pubmed
pubmed-article:11495417	pubmed:dateRevised	2005-11-16	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:meshHeading	pubmed-meshheading:11495417...	lld:pubmed
pubmed-article:11495417	pubmed:articleTitle	Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.	lld:pubmed
pubmed-article:11495417	pubmed:affiliation	SBU Therapeutics, Schering AG Berlin, Germany. Reinhard.Horowski@Schering.de	lld:pubmed
pubmed-article:11495417	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:11495417	pubmed:publicationType	Review	lld:pubmed